Laura Vander Poel, DPM
Foot & Ankle Surgery · Enfield, CTNPI 1477781383
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $380 and has fallen 93.6% since, to $24 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in CT, where the typical reported total is $1,838.
Across 18 payments — averaging $45.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$192
- Davol Inc.$191
- Bioventus LLC$109
- KCI USA, Inc.$91
- Osiris Therapeutics Inc.$72
- Smith+Nephew$55
- plus $101 from 4 others
What the payments were for
- Food & beverage$812100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $192 |
| Davol Inc. | 2 | $191 |
| Bioventus LLC | 5 | $109 |
| KCI USA, Inc. | 1 | $91 |
| Osiris Therapeutics Inc. | 1 | $72 |
| Smith+Nephew | 2 | $55 |
| Hydrofera LLC | 2 | $43 |
| Amgen | 1 | $24 |
| Baxter Healthcare | 1 | $21 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$146
How this compares
$812 in reported general payments places this provider in the 35th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 89 | $2,258 |
| Ketoconazole | 61 | $957 |
| Silver Sulfadiazine | 55 | $339 |
| Doxycycline Monohydrate | 14 | $192 |
| Methylprednisolone | 24 | $183 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $137 |
| SsdSilver Sulfadiazine | 15 | $118 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Enfield
- Thomas McDonaldEnfield$241K
- Matthew TschudyEnfield$4K
- Kristen WintersEnfield$3K
- Rebecca WiesnerEnfield$3K
- Kayla O MalleyEnfield$2K
- Charlotte GeorgeEnfield$2K
- Elizabeth SchwartzEnfield$1K
- Thomas JohnsonEnfield$683
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.